| Current Price | $74.62 | Mkt Cap | $188.7B |
|---|---|---|---|
| Open | $74.21 | P/E Ratio | 26.83 |
| Prev. Close | $74.62 | Div. (Yield) | $2.60 (3.5%) |
| Daily Range | $74.08 - $75.00 | Volume | 10,407,384 |
| 52-Wk Range | $65.25 - $87.80 | Avg. Daily Vol. | 10,129,857 |
A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.
| Current Price | $74.62 | Mkt Cap | $188.7B |
|---|---|---|---|
| Open | $74.21 | P/E Ratio | 26.83 |
| Prev. Close | $74.62 | Div. (Yield) | $2.60 (3.5%) |
| Daily Range | $74.08 - $75.00 | Volume | 10,407,384 |
| 52-Wk Range | $65.25 - $87.80 | Avg. Daily Vol. | 10,129,857 |
The best Bull and Bear pitches based on recency and number of recommendations.
Terrible leadership + atrocious decision making has fostered a culture of fear and indifference. Not sure how that bolsters the pipeline.
Read the most recent pitches from players about MRK.
Recs
quinpeung
(91.89)
Submitted: 1/18/2021 6:17:37 PM :
Start Price:
$81.84
NYSE:MRK Score:
-9.88
Symmetrical triangle pattern, poised for breakout...
Recs
Dividends500
(82.95)
Submitted: 1/1/2021 6:48:30 PM :
Start Price:
$82.00
NYSE:MRK Score:
-10.87
Dividends500 tracks the healthiest dividends in the S&P 500.
To qualify for the portfolio, the company must meet three simple requirements:
- Member of the S&P 500
- Payout ratio below 50%
- Dividend growth year over year
Recs
Luvy0712
(62.07)
Submitted: 12/29/2020 9:20:04 PM :
Start Price:
$80.80
NYSE:MRK Score:
-10.33
The new $350 million contract with the US govt for the covid experimental drug will boost its price in the Q2,Q3 of 2021. Doses are expected by mid next year. Strong chance of growth
Find the members with the highest scoring picks in MRK.
TrackTobinSmith (< 20) Score: +174.33
The Score Leader is the player with the highest score across all their picks in MRK.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| kaliblade | 85.03 | 2/12/2009 |
|
3W | $19.25 | +287.60% | +373.61% | +86.02 | 0 Comment | |
| dbwhiz57 | 68.96 | 12/17/2007 |
|
1Y | $37.47 | +99.14% | +176.09% | +76.95 | 0 Comment | |
| fraley250r | < 20 | 1/7/2008 |
|
NS | $35.98 | +107.40% | +180.97% | +73.57 | 0 Comment | |
| prettymeadow | < 20 | 3/20/2009 |
|
3M | $17.81 | +318.90% | +390.49% | +71.59 | 0 Comment | |
| bubba1986 | 22.84 | 1/23/2008 |
|
3W | $31.22 | +139.01% | +209.87% | +70.86 | 0 Comment | |
| TMFSpeck | 67.83 | 2/12/2010 |
|
5Y | $25.50 | +192.62% | +255.66% | +63.03 | 0 Comment | |
| fordfest99 | 40.23 | 3/26/2009 |
|
3Y | $18.50 | +303.44% | +366.13% | +62.69 | 0 Comment | |
| birdienumnum | 88.72 |
|
|
5Y | $20.07 | +271.81% | +209.33% | +62.48 | 0 Comment | |
| JoeySly | 90.03 | 3/6/2009 |
|
3W | $14.96 | +398.75% | +460.67% | +61.92 | 0 Comment | |
| buckywildcat | < 20 | 1/26/2009 |
|
1Y | $18.49 | +303.62% | +365.45% | +61.84 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
